SCHEMBL8070879

SCHEMBL8070879

CCCCc1nc(CO)c(Cl)n1Cc1ccc(-c2ccccc2)c(C#N)c1

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 4/20 0.59
AGTR2 P50052 4/20 0.59
PPARG P37231 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3460736 0.89 AGTR1 (0.62) AGTR1AGTR2PPARG
SCHEMBL7177667 0.87 AGTR1 (0.63) AGTR1AGTR2
SCHEMBL8076001 0.84 AGTR1 (0.65) AGTR1AGTR2
SCHEMBL11092792 0.83 AGTR1 (0.63) AGTR1AGTR2
SCHEMBL7326958 0.82 AGTR1 (0.60) AGTR1AGTR2
SCHEMBL9443092 0.82 PPARG (0.68) AGTR1AGTR2PPARG
SCHEMBL9638129 0.82 PPARG (0.57) AGTR1AGTR2PPARG
SCHEMBL9443042 0.81 PPARG (0.49) AGTR1AGTR2PPARG
SCHEMBL7325291 0.80 PPARG (0.57) AGTR1AGTR2PPARG
SCHEMBL9844285 0.80 AGTR1 (0.46) AGTR1AGTR2PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1019048-A1 USE OF AN ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREPARATION OF DRUGS TO INCREASE THE SURVIVAL RATE OF RENAL TRANSPLANT PATIENTS Merck Sharp Dohme (Italia) S.P.A. (IT) 2000-07-19 EP disclosed
WO-1999016437-A1 USE OF AN ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREPARATION OF DRUGS TO INCREASE THE SURVIVAL RATE OF RENAL TRANSPLANT PATIENTS MERCK SHARP DOHME (ITALIA) S.P.A. (IT) 1999-04-08 WO disclosed